FDA Issues Guidance for Compounding Starter Parenteral Nutrition Drug Products for Neonates

The Food and Drug Administration (FDA) has announced the availability of new guidance for industry titled 'Temporary Policies for Compounding Certain Starter Parenteral Nutrition Drug Products for Neonates.' This guidance aims to provide temporary policies for the compounding of these critical drug products.